Chair, Department of Radiology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York; Senior Vice President/Regional Executive Director, Northwell Health, Manhasset, New York; Feinstein Institutes for Medical Research, Manhasset, New York.
Siemens Medical Solutions USA, Inc, Malvern, Pennsylvania; Visiting Scholar, Feinstein Institutes for Medical Research, Manhasset, New York.
J Am Coll Radiol. 2020 Jul;17(7):865-872. doi: 10.1016/j.jacr.2020.05.004. Epub 2020 May 16.
The coronavirus disease 2019 (COVID-19) pandemic has had significant economic impact on radiology with markedly decreased imaging case volumes. The purpose of this study was to quantify the imaging volumes during the COVID-19 pandemic across patient service locations and imaging modality types.
Imaging case volumes in a large health care system were retrospectively studied, analyzing weekly imaging volumes by patient service locations (emergency department, inpatient, outpatient) and modality types (x-ray, mammography, CT, MRI, ultrasound, interventional radiology, nuclear medicine) in years 2020 and 2019. The data set was split to compare pre-COVID-19 (weeks 1-9) and post-COVID-19 (weeks 10-16) periods. Independent-samples t tests compared the mean weekly volumes in 2020 and 2019.
Total imaging volume in 2020 (weeks 1-16) declined by 12.29% (from 522,645 to 458,438) compared with 2019. Post-COVID-19 (weeks 10-16) revealed a greater decrease (28.10%) in imaging volumes across all patient service locations (range 13.60%-56.59%) and modality types (range 14.22%-58.42%). Total mean weekly volume in 2020 post-COVID-19 (24,383 [95% confidence interval 19,478-29,288]) was statistically reduced (P = .003) compared with 33,913 [95% confidence interval 33,429-34,396] in 2019 across all patient service locations and modality types. The greatest decline in 2020 was seen at week 16 specifically for outpatient imaging (88%) affecting all modality types: mammography (94%), nuclear medicine (85%), MRI (74%), ultrasound (64%), interventional (56%), CT (46%), and x-ray (22%).
Because the duration of the COVID-19 pandemic remains uncertain, these results may assist in guiding short- and long-term practice decisions based on the magnitude of imaging volume decline across different patient service locations and specific imaging modality types.
2019 年冠状病毒病(COVID-19)大流行对放射科产生了重大的经济影响,影像学检查量明显减少。本研究的目的是量化 COVID-19 大流行期间各患者服务地点和影像学方式类型的影像学检查量。
对一个大型医疗保健系统的影像学检查量进行回顾性研究,分析 2020 年和 2019 年各患者服务地点(急诊科、住院部、门诊部)和影像学方式类型(X 线、乳腺 X 线摄影术、CT、MRI、超声、介入放射学、核医学)的每周影像学检查量。数据集被分割以比较 COVID-19 之前(第 1-9 周)和 COVID-19 之后(第 10-16 周)的时期。独立样本 t 检验比较了 2020 年和 2019 年的每周平均量。
与 2019 年相比,2020 年(第 1-16 周)的总影像学检查量下降了 12.29%(从 522645 降至 458438)。COVID-19 之后(第 10-16 周),所有患者服务地点(范围 13.60%-56.59%)和影像学方式类型(范围 14.22%-58.42%)的影像学检查量都出现了更大幅度的下降。COVID-19 之后,2020 年每周的总平均量(24383[95%置信区间 19478-29288])明显减少(P=0.003),而所有患者服务地点和影像学方式类型的 2019 年为 33913[95%置信区间 33429-34396]。2020 年下降幅度最大的是第 16 周的门诊影像学(88%),影响了所有影像学方式:乳腺 X 线摄影术(94%)、核医学(85%)、MRI(74%)、超声(64%)、介入放射学(56%)、CT(46%)和 X 线摄影术(22%)。
由于 COVID-19 大流行的持续时间仍不确定,这些结果可能有助于根据不同患者服务地点和特定影像学方式类型的影像学检查量下降幅度来指导短期和长期的实践决策。